In the BioHarmony Drug Report Database

"Preview" Icon

Pegvisomant

Somavert (pegvisomant) is a protein pharmaceutical. Pegvisomant was first approved as Somavert on 2002-11-12. It is used to treat acromegaly in the USA. It has been approved in Europe to treat acromegaly. The pharmaceutical is active against growth hormone receptor.

 

Trade Name

 

Somavert
 

Common Name

 

pegvisomant
 

ChEMBL ID

 

CHEMBL1201515
 

Indication

 

acromegaly
 

Drug Class

 

Pegylated compounds

Image (chem structure or protein)

Pegvisomant structure rendering